CCC Stock Overview
Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Cilo Cybin Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R2.00 |
52 Week High | R10.00 |
52 Week Low | R2.00 |
Beta | 0 |
11 Month Change | -48.72% |
3 Month Change | -54.55% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -5.88% |
Recent News & Updates
Recent updates
Shareholder Returns
CCC | ZA Pharmaceuticals | ZA Market | |
---|---|---|---|
7D | -42.7% | -1.0% | 1.7% |
1Y | n/a | 0.8% | 15.6% |
Return vs Industry: Insufficient data to determine how CCC performed against the ZA Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how CCC performed against the ZA Market.
Price Volatility
CCC volatility | |
---|---|
CCC Average Weekly Movement | 27.8% |
Pharmaceuticals Industry Average Movement | 6.3% |
Market Average Movement | 4.5% |
10% most volatile stocks in ZA Market | 9.5% |
10% least volatile stocks in ZA Market | 2.6% |
Stable Share Price: CCC's share price has been volatile over the past 3 months compared to the ZA market.
Volatility Over Time: Insufficient data to determine CCC's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | n/a | Gabriel Theron | www.cilocybin.com |
Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide. The company offers THC and CBD oil bottles; cannabis flowers and vape products; tinctures and edibles; topicals, capsules, and devices; full and broad spectrum refined crude oil; CBD and THC distillates; and CBD, CBG, CBN, THC isolates. It also provides cannabis packaging services, storage, and exportation services to the cannabis industry.
Cilo Cybin Holdings Limited Fundamentals Summary
CCC fundamental statistics | |
---|---|
Market cap | R142.04m |
Earnings (TTM) | R455.44k |
Revenue (TTM) | n/a |
311.9x
P/E Ratio0.0x
P/S RatioIs CCC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CCC income statement (TTM) | |
---|---|
Revenue | R0 |
Cost of Revenue | R0 |
Gross Profit | R0 |
Other Expenses | -R455.43k |
Earnings | R455.44k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.0064 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 1.0% |
How did CCC perform over the long term?
See historical performance and comparison